PENTOKEY ORGANY (INDIA) LTD.

Pentokey Organy India Ltd has announced the closure of its trading window for dealing in securities. The window will be shut from July 1, 2026, and will reopen 48 hours after the company's unaudited financial results for the quarter ended June 30, 2026, are made public. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. All directors and designated persons have been informed not to trade during this period to prevent potential insider trading.

Pentokey Organy India Ltd has released its audited standalone financial results for the quarter and financial year ended March 31, 2026. The results, approved by the Board of Directors, include an unmodified audit opinion from M/s Verma Mehta & Associates. The company's revenue from operations for the year ended March 31, 2026, was ₹209.00 Lakh. The results pertain to trading in the Pharma/Pesticides segment.

Pentokey Organy India Ltd's Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026. The statutory auditors, Verma Mehta & Associates, issued an unmodified opinion on the financial statements. The meeting commenced at 5:00 PM and concluded at 6:00 PM.

Pentokey Organy India Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The trading window, currently closed as per insider trading regulations, will reopen 48 hours after the financial results are made public. The information has been uploaded to the company's website.

Pentokey Organy India Ltd has announced the closure of its trading window from 1st April, 2026, in accordance with the SEBI (Prohibition of Insider Trading) Regulation, 2015 and the Company's Code of Conduct for Prevention of Insider Trading. The window will reopen 48 hours after the unaudited Financial Results of the Company for the Quarter ended 31st March, 2026 become generally available. Directors and Designated Persons have been informed not to trade in the securities of the Company during this closure period.

Pentokey Organy India Ltd has announced its unaudited financial results for the quarter and nine months ended 31st December 2025. The company's revenue from operations stands at INR 395.39 lakh for the quarter and INR 82.62 lakh for the nine months period. The total income for the quarter is INR 418.54 lakh and INR 60.30 lakh for the nine months period. The company's profit before exceptional items and tax for the quarter is INR 3.78 lakh and INR 33.41 lakh for the nine months period. The earnings per equity share for the quarter is INR 0.06 and INR 0.53 for the nine months period.

Pentokey Organy India Ltd has released its unaudited financial results for the quarter and nine months ended 31st December, 2025. The company's revenue from operations stands at ₹ 209.14 lakh for the quarter and ₹ 418.54 lakh for the nine months period. The net profit for the quarter is ₹ 3.78 lakh and ₹ 33.41 lakh for the nine months period. The company's total expenses for the quarter are ₹ 171.31 lakh and ₹ 385.13 lakh for the nine months period.

Pentokey Organy India Ltd has announced a meeting of the Board of Directors on 21st January 2026. The agenda includes the consideration and approval of the unaudited Financial Results of the Company for the quarter ended 31st December 2025. The trading window for dealing in securities of the Company, currently closed due to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, will reopen 48 hours after the financial results become generally available. The announcement was made in accordance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the intimation has been uploaded on the Company’s website.

Pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015, Pentokey Organy India Ltd has announced that the trading window for trading/dealing in the securities of the Company will remain closed from 1st January, 2026 and will re-open 48 hours after the unaudited Financial Results of the Company for the Quarter ended 31st December, 2025 become generally available. This decision is in accordance with the Company's Code of Conduct for Prevention of Insider Trading and BSE Circular Ref. No. LIST/COMP/01/2019-20 dated 2nd April, 2019.

Pentokey Organy India Ltd has reported its unaudited financial results for the quarter and half year ended 30th September, 2025. The company's revenue from operations stands at 98.33 lakh for the quarter and 506.20 lakh for the half year. The net profit for the quarter is 14.23 lakh and 48.47 lakh for the half year. The company's total income and expenses for the quarter and half year are also reported.